Cancer Therapy News and Articles

Return to Library

Recent Cancer Therapy News and Articles

• Researchers from Department of Medical Oncology Detail New Studies and Findings in the Area of Cancer Therapy
• Researchers from Naval Medical Research Institute Detail New Studies and Findings in the Area of Toxicology and Pharmacology
• Researchers from University of Science Malaysia Publish Findings in Cancer Therapy
• Scientists at University of Southern California Detail Research in Sulfides
• Studies from Institute for Biotechnology in the Area of Cancer Therapy Published
• Studies from University of Namur Have Provided New Data on Small Interference RNAs (siRNAs)
• Study Data from Taipei Veterans General Hospital Update Understanding of Cancer Therapy
• Study Findings from M.S. Aapro et al Provide New Insights into Cancer Therapy
• Researchers from University of Texas Southwestern Medical Center Report on Findings in Breast Cancer

---

Research Results from University of Glasgow Update Knowledge of Cancer Therapy

2013 JAN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Fresh data on Cancer Therapy are presented in a new report. According to news reporting from Glasgow, United Kingdom, by NewsRx journalists, research stated, "Regulatory T cells (Tregs) are crucial in mediating immune homeostasis and promoting the establishment and maintenance of peripheral tolerance. However, in the context of cancer their role is more complex, and they are thought to contribute to the progress of many tumours."

The news correspondents obtained a quote from the research from the University of Glasgow, "As cancer cells express both self- and tumour-associated antigens, Tregs are key to dampening effector cell responses, and therefore represent one of the main obstacles to effective anti-tumour responses. Suppression mechanisms employed by Tregs are thought to contribute significantly to the failure of current therapies that rely on induction or potentiation of anti-tumour responses. This review will focus on the current evidence supporting the central role of Tregs in establishing tumour-specific tolerance and promoting cancer escape. We outline the mechanisms underlying their suppressive function and discuss the potential routes of Tregs accumulation within the tumour, including enhanced recruitment, in-situ or local proliferation, and de-novo differentiation. In addition, we review some of the cancer treatment strategies that act, at least in part, to eliminate or interfere with the function of Tregs."

According to the news reporters, the research concluded: "The role of Tregs is being recognized increasingly in cancer, and controlling the function of these suppressive cells in the tumour microenvironment without compromising peripheral tolerance represents a significant challenge for cancer therapies."

For more information on this research see: Suppression, subversion and escape: the role of regulatory T cells in cancer progression. Clinical and Experimental Immunology, 2013;171(1):36-45. Clinical and Experimental Immunology can be contacted at: Wiley-Blackwell, 111 River St, Hoboken 07030-5774, NJ, USA. (Wiley-Blackwell - www.wiley.com/; Clinical and Experimental Immunology - onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2249)

Our news journalists report that additional information may be obtained by contacting K. Oleinika, University of Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Chemokine Res Grp, Glasgow G12 8TA, Lanark, United Kingdom.

Keywords for this news article include: Europe, Glasgow, Oncology, United Kingdom, Cancer Therapy

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC